Eisana Health

Reducing permanent nerve damage from chemotherapy

https://wefunder.com/eisana.health

Total raised on Wefunder: 57461

Total investors: 30

Quick facts

  • 2025 American Cancer Society BrightEdge Entrepreneur
  • Completed functional prototype
  • Completed Usability Study in humans
  • Developed only mobile device that allows functionality in hands and feet while cooling
  • Filed several patents in the US and selected countries
  • Received $400k SBIR Contract from the National Cancer Institute to specifically develop this device
  • Founder and team each have decades of relevant experience
  • Large market - 500,000 US cancer patients per year need this device

Team profiles

Featured investor profiles

Invest in Eisana Health

Reducing permanent nerve damage from chemotherapy

$288,461

of a $1,200,000 goal
INVESTMENT TERMS
Convertible Note
$8M valuation cap 8% interest 20% discount
Posts